mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.2 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
bid1870 |
gCSI |
pan-cancer |
AAC |
-0.068 |
0.2 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.2 |
mRNA |
CI-1040 |
GDSC1000 |
pan-cancer |
AAC |
-0.041 |
0.2 |
mRNA |
BRD-K70511574 |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.2 |
mRNA |
ML006 |
CTRPv2 |
pan-cancer |
AAC |
0.045 |
0.2 |
mRNA |
ruxolitinib |
GDSC1000 |
pan-cancer |
AAC |
0.041 |
0.2 |
mRNA |
JW-74 |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.2 |
mRNA |
BRD-K55116708 |
CTRPv2 |
pan-cancer |
AAC |
0.044 |
0.2 |